Literature DB >> 11854232

Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis.

Yidong Du1, Roland Rosqvist, Ake Forsberg.   

Abstract

Yersinia pestis, the causative agent of plague, expresses a capsule-like antigen, fraction 1 (F1), at 37 degrees C. F1 is encoded by the caf1 gene located on the large 100-kb pFra plasmid, which is unique to Y. pestis. F1 is a surface polymer composed of a protein subunit, Caf1, with a molecular mass of 15.5 kDa. The secretion and assembly of F1 require the caf1M and caf1A genes, which are homologous to the chaperone and usher protein families required for biogenesis of pili. F1 has been implicated to be involved in the ability of Y. pestis to prevent uptake by macrophages. In this study we addressed the role of F1 antigen in inhibition of phagocytosis by the macrophage-like cell line J774. The Y. pestis strain EV76 was found to be highly resistant to uptake by J774 cells. An in-frame deletion of the caf1M gene of the Y. pestis strain EV76 was constructed and found to be unable to express F1 polymer on the bacterial surface. This strain had a somewhat lowered ability to prevent uptake by J774 cells. Strain EV76C, which is cured for the virulence plasmid common to the pathogenic Yersinia species, was, as expected, much reduced in its ability to resist uptake. A strain lacking both the virulence plasmid and caf1M was even further hampered in the ability to prevent uptake and, in this case, essentially all bacteria (95%) were phagocytosed. Thus, F1 and the virulence plasmid-encoded type III system act in concert to make Y. pestis highly resistant to uptake by phagocytes. In contrast to the type III effector proteins YopE and YopH, F1 did not have any influence on the general phagocytic ability of J774 cells. Expression of F1 also reduced the number of bacteria that interacted with the macrophages. This suggests that F1 prevents uptake by interfering at the level of receptor interaction in the phagocytosis process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854232      PMCID: PMC127752          DOI: 10.1128/IAI.70.3.1453-1460.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

1.  Structural and functional similarity between Yersinia pestis capsular protein Caf1 and human interleukin-1 beta.

Authors:  V M Abramov; A M Vasiliev; R N Vasilenko; N L Kulikova; I V Kosarev; V S Khlebnikov; A T Ishchenko; S MacIntyre; J R Gillespie; R Khurana; T Korpela; A L Fink; V N Uversky
Journal:  Biochemistry       Date:  2001-05-22       Impact factor: 3.162

2.  Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia.

Authors:  K L Guan; J E Dixon
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

3.  Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions.

Authors:  D S Black; J B Bliska
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

4.  The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions.

Authors:  C Persson; N Carballeira; H Wolf-Watz; M Fällman
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

5.  Characterization of the operon encoding the YpkA Ser/Thr protein kinase and the YopJ protein of Yersinia pseudotuberculosis.

Authors:  E E Galyov; S Håkansson; H Wolf-Watz
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

6.  Essential virulence determinants of different Yersinia species are carried on a common plasmid.

Authors:  R Ben-Gurion; A Shafferman
Journal:  Plasmid       Date:  1981-03       Impact factor: 3.466

7.  Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice.

Authors:  W J Simpson; R E Thomas; T G Schwan
Journal:  Am J Trop Med Hyg       Date:  1990-10       Impact factor: 2.345

8.  Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops).

Authors:  K J Davis; D L Fritz; M L Pitt; S L Welkos; P L Worsham; A M Friedlander
Journal:  Arch Pathol Lab Med       Date:  1996-02       Impact factor: 5.534

9.  A highly efficient electroporation system for transformation of Yersinia.

Authors:  R F Conchas; E Carniel
Journal:  Gene       Date:  1990-03-01       Impact factor: 3.688

10.  Characterization of common virulence plasmids in Yersinia species and their role in the expression of outer membrane proteins.

Authors:  D A Portnoy; H Wolf-Watz; I Bolin; A B Beeder; S Falkow
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

View more
  123 in total

1.  Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis.

Authors:  Jim Hill; Catherine Copse; Sophie Leary; Anthony J Stagg; E Diane Williamson; Richard W Titball
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 2.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

3.  Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.

Authors:  Alexander V Philipovskiy; Stephen T Smiley
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

4.  Proteomic characterization of Yersinia pestis virulence.

Authors:  Brett A Chromy; Megan W Choi; Gloria A Murphy; Arlene D Gonzales; Chris H Corzett; Brian C Chang; J Patrick Fitch; Sandra L McCutchen-Maloney
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

5.  Transcriptomic and innate immune responses to Yersinia pestis in the lymph node during bubonic plague.

Authors:  Jason E Comer; Daniel E Sturdevant; Aaron B Carmody; Kimmo Virtaneva; Donald Gardner; Dan Long; Rebecca Rosenke; Stephen F Porcella; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

6.  Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis.

Authors:  Debaditya Bhattacharya; Joan Mecsas; Linden T Hu
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

7.  Characterization of phagosome trafficking and identification of PhoP-regulated genes important for survival of Yersinia pestis in macrophages.

Authors:  Jens P Grabenstein; Hana S Fukuto; Lance E Palmer; James B Bliska
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 8.  Evolution of the chaperone/usher assembly pathway: fimbrial classification goes Greek.

Authors:  Sean-Paul Nuccio; Andreas J Bäumler
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

9.  Yersinia pestis IS1541 transposition provides for escape from plague immunity.

Authors:  Claire A Cornelius; Lauriane E Quenee; Derek Elli; Nancy A Ciletti; Olaf Schneewind
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

10.  Early evolutionary loss of the lipid A modifying enzyme PagP resulting in innate immune evasion in Yersinia pestis.

Authors:  Courtney E Chandler; Erin M Harberts; Mark R Pelletier; Iyarit Thaipisuttikul; Jace W Jones; Adeline M Hajjar; Jason W Sahl; David R Goodlett; Aaron C Pride; David A Rasko; M Stephen Trent; Russell E Bishop; Robert K Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.